GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...

COP29 President-Designate around November’s global climate conference. And reviewing the insights from a recent look at how ...

The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...

Johnson & Johnson (J&J) and Protagonist Therapeutics have announced positive top-line results from a late-stage study of ...

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...